A systematic study of the effect of physiological factors on β2-microglobulin amyloid formation at neutral pH

Biochemistry

Volumn 45, Issue 7, 2006, Pages 2311-2321

  Myers, Sarah L ^a   Jones, Susan ^a,c   Jahn, Thomas R ^a   Morten, Isobel J ^a   Tennent, Glenys A ^b   Hewitt, Eric W ^a   Radford, Sheena E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; MONOMERS; PH EFFECTS; PHYSIOLOGY;

FIBRILLOGENESIS; NEUTRAL PH; RECOMBINANT PROTEIN; SERUM AMYLOID P COMPONENT (SAP);

PROTEINS;

AMYLOID; APOLIPOPROTEIN E; BETA 2 MICROGLOBULIN; DETERGENT; GLYCOSAMINOGLYCAN; HEPARIN; PROTEOGLYCAN; RECOMBINANT PROTEIN; SERUM AMYLOID P; SOLVENT;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; MUSCULOSKELETAL SYSTEM; PH; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FOLDING; PROTEIN STABILITY; SYNOVIAL FLUID; SYNOVIUM; THERMODYNAMICS; UREMIA;

EID: 33144471714     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi052434i     Document Type: Article

References (67)

1. Westermark, P., Benson, M. D., Buxbaum, J. N., Cohen, A. S., Frangione, B., Ikeda, S., Masters, C. L., Merlini, G., Saraiva, M. J., and Sipe, J. D. (2005) Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 12, 1-4.
2. Floege, J., and Ketteler, M. (2001) Beta-2-microglobulin derived amyloidosis: an update. Kidney Int. 59, 164-171.
3. Inoue, S., Kuroiwa, M., Ohashi, K., Kara, M., and Kisilevsky, R. (1997) Ultrastructural organization of hemodialysis-associated beta-2-microglobulin amyloid fibrils. Kidney Int. 52, 1543-1549.
4. Miyata, T., Jadoul, M., Kurokawa, K., and Van Ypersele de Strihou, C. (1998) Beta-2-microglobulin in renal disease. J. Am. Soc. Nephrol. 9, 1723-1735.
5. Floege, J., and Ehlerding, G. (1996) Beta-2-microglobulin associated amyloidosis. Nephron 72, 9-26.
6. Gejyo, F., Yamada, T., Odani, S., Nakagawa, Y., Arakawa, M., Kunitomo, T., Kataoka, H., Suzuki, M., Hirasawa, Y., Shirahama, T., Cohen, A. S., and Schmid, K. (1985) A new form of amyloid protein associated with chronic hemodialysis was identified as beta-2-microglobulin. Biochem. Biophys. Res. Commun. 129, 701-706.
7. Gorevic, P. D., Munoz, P. C., Casey, T. T., DiRaimondo, C. R., Stone, W. J., Prelli, F. C., Rodrigues, M. M., Poulik, M. D., and Frangione, B. (1986) Polymerization of intact beta-2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc. Natl. Acad. Sci. U.S.A. 83, 7908-7912.
8. Jahn, T. R., and Radford, S. E. (2005) Beta-2-microglobulin. in Amyloid Proteins: The Beta Sheet Conformation and Diseases, (Sipe, J. D., Ed.) Wiley-VCH, Weinheim.
9. Naiki, H., Hashimoto, N., Suzuki, S., Kimura, H., Nakakuki, K., and Gejyo, F. (1997) Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro. Amyloid Int. J. Exp. Clin. Invest. 4, 223-232.
10. Smith, D. P., Jones, S., Serpell, L. C., Sunde, M., and Radford, S. E. (2003) A systematic investigation into the effect of protein destabilisation on beta-2-microglobulin amyloid formation. J. Mol. Biol. 330, 943-954.
11. Gosal, W. S., Morten, I. J., Hewitt, E. W., Smith, D. A., Thomson, N. H., and Radford, S. E. (2005) Competing pathways determine fibril morphology in the self-assembly of beta-2-microglobulin into amyloid. J. Mol. Biol. 351, 850-864.
12. Kad, N. M., Thomson, N. H., Smith, D. P., Smith, D. A., and Radford, S. E. (2001) Beta-2-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. J. Mol. Biol. 313, 559-571.
13. Morgan, C. J., Gelfand, M., Atreya, C., and Miranker, A. D. (2001) Kidney dialysis-associated amyloidosis: a molecular role for copper in fibre formation. J. Mol. Biol. 309, 339-345.
14. Jones, S., Smith, D. P., and Radford, S. E. (2003) Destabilisation in the N- and C-terminal strands of beta-2-microglobulin results in amyloid formation at neutral pH. J. Mol. Biol. 330, 935-941.
15. Yamamoto, S., Yamaguchi, I., Hasegawa, K., Tsutsumi, S., Goto, Y., Gejyo, F., and Naiki, H. (2004) Glycosaminoglycans enhance the trifluoroethanol- induced extension of beta-2-microglobulin related amyloid fibrils at neutral pH. J. Am. Soc. Nephrol. 15, 126-133.
16. Yamamoto, S., Hasegawa, K., Yamaguchi, I, Tsutsumi, S., Kardos, J., Goto, Y., Gejyo, F., and Naiki, H. (2004) Low concentrations of sodium dodecyl sulphate induce the extension of beta-2-microglobulin related amyloid fibrils at neutral pH. Biochemistry 43, 11075-11082.
17. Alexandrescu, A. T. (2005) Amyloid accomplices and enforcers. Protein Sci. 14, 1-12.
18. van Horssen, J., Wesseling, P., van den Heuvel, L. P., de Waal, R. M., and Verbeek, M. M. (2003) Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders. Lancet Neural. 2, 482-492.
19. Linke, R. P., Hampl, H., Bartel-Schwarze, S., and Eulitz, M. (1987) Beta-2-microglobulin, different fragments and polymers thereof in synovial amyloid in long-term hemodialysis. Biol. Chem. Hoppe-Seyler 368, 137-144.
20. Stoppini, M., Mangione, P., Monti, M., Giorgetti, S., Marchese, L., Arcidiaco, P., Verga, L., Segagni, S., Pucci, P., Merlini, G., and Bellotti, V. (2005) Proteomics of beta-2-microglobulin amyloid fibrils. Biochim. Biophys. Acta 1751, 23-33.
21. Gill, S., and Von Hippel, P. H. (1989) Calculation of protein extinction coeffients from amino acid sequence data. Anal. Biochem. 182, 319-326.
22. Pepys, M. B., Booth, D. R., Hutchinson, W. L., Gallimore, J. R., Collins, P. M., and Hohenester, E. (1997) Amyloid P component. A critical review. Amyloid: Int. J. Exp. Clin. Invest. 4, 274-295.
23. Friel, C. T., Beddard, G. S., and Radford, S. E. (2004) Switching two-state to three-state kinetics in the helical protein Im9 via the optimization of stabilizing non-native interactions by design. J. Mol. Biol. 342, 261-213.
24. Nilsson, M. R. (2004) Techniques to study amyloid fibril formation in vitro. Methods 34, 151-160.
25. Tennent, G. A. (1999) Isolation and characterization of amyloid fibrils from tissue. Methods Enzymol. 309, 26-47.
26. Kayed, R. H. E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489.
27. Esposito, G., Michelutti, R., Verdone, G., Viglino, P., Hernandez, H., Robinson, C. V., Amoresano, A., Dal Piaz, F., Monti, M., Pucci, P., Mangione, P., Stoppini, M., Merlini, G., Ferri, G., and Bellotti, V. (2000) Removal of the N-terminal hexapeptide from human beta-2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci. 9, 831-845.
28. Kisilevsky, R., Szarek, W. A., Ancsin, J., Vohra, R., Li, Z., and Marone, S. (2004) Novel glycosaminoglycan precursors as antiamyloid agents: Part IV. J. Mol. Neurosci. 24, 167-172.
29. Nishi, S., Ogino, S., Maruyama, Y., Honma, N., Gejyo, F., Morita, T., and Arakawa, M. (1990) Electron-microscopic and immunohistochemical study of beta-2-microglobulin-related amyloidosis. Nephron 56, 357-363.
30. Yamaguchi, I., Suda, H., Tsuzuike, N., Seto, K., Seki, M., Yamaguchi, Y., Hasegawa, K., Takahashi, N., Yamamotot, S., Gejyo, F., and Naiki, H. (2003) Glycosaminoglycan and proteoglycan inhibit the deoplymerisation of beta-2-microgloulin amyloid fibrils in vitro. Kidney Int. 64, 1080-1088.
31. Webb, A. R., Mythen, M. G., Jacobson, D., and Mackie, I. J. (1995) Maintaining blood flow in the extracorporeal circuit: hemostasis and anticoagulation. Intensive Care Med. 21, 84-93.
32. Klunk, W. E., Jacob, R. F., and Mason, R. P. (1999) Quantifying amyloid beta-peptide (A-beta) aggregation using the Congo red A-beta (CR-A beta) spectrophotometric assay. Anal. Biochem. 266, 66-76.
33. O'Nuallain, B., and Wetzel, R. (2002) Conformational Abs recognizing a generic amyloid fibril epitope. Proc. Natl. Acad. Sci. U.S.A. 99, 1485-1490.
34. Ohashi, Y., Kisilevsky, R., and Yanagishita, M. (2002) Affinity binding of glycosaminoglycans with beta-2-microglobulin. Nephron 90, 158-168.
35. Tan, S., Baillod, R., Brown, E., Farrington, K., Soper, C., Percy, M., Clutterbuck, E., Madhoo, S., Pepys, M., and Hawkins, P. (1999) Clinical, radiological and serum amyloid P component scintigraphic features of beta-2-microglobulin amylidosis associated with continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant. 14, 1467-1471.
36. Yamaguchi, I., Hasegawa, K., Takahashi, N., Yamamoto, S., Gejyo, F., and Naiki, H. (2001) Apolipoprotein E inhibits the depolymerisation of beta-2-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry 40, 8499-8507.
37. Homma, N., Gejyo, F., Isemura, M., and Arakawa, M. (1989) Collagen-binding affinity of beta-2-microglobulin, a preprotein of hemodialysis-associated amyloidosis. Nephron 53, 37-40.
38. Moe, S. M., and Chen, N. X. (2001) The role of the synovium and cartilage in the pathogenesis of beta-2-microglobulin amyloidosis. Semin. Dial. 14, 127-130.
39. Giorgetti, S., Rossi, A., Mangione, P., Raimondi, S., Marini, S., Stoppini, M., Corazza, A., Viglino, P., Esposito, G., Cetta, G., Merlini, G., and Bellotti, V. (2005) Beta-2-microglobulin isoforms display an heterogeneous affinity for type I collagen. Protein Sci. 14, 1-7.
40. Gejyo, F., Suzuki, S., Kimura, H., Imura, T., Ei, I., Hasegawa, H., and Arakawa, M. (1997) Increased risk of dialysis-related amyloidosis in patients with the apolipoprotein E4 allele. Amyloid Int. J. Exp. Clin. Invest. 4, 13-17.
41. Ono, K., and Uchino, F. (1994) Formation of amyloid-like substance from beta-2-microglobulin in vitro. Role of serum amyloid P component: a preliminary study. Nephron 66, 404-407.
42. McParland, V. J., Kad, N. M., Kalverda, A. P., Brown, A., Kirwin-Jones, P., Hunter, M. G., Sunde, M., and Radford, S. E. (2000) Partially unfolded states of beta-2-microglobulin and amyloid formation in vitro. Biochemistry 39, 8735-8746.
43. Yamaguchi, K., Katou, H., Hoshino, M., Hasegawa, K., Naiki, H., and Goto, Y. (2004) Core and heterogeneity of beta-2-microglobulin amyloid fibrils as revealed by H/D exchange. J. Mol. Biol. 338, 559-571.
44. Ivanova, M. I., Sawaya, M. R., Gingery, M., Attinger, A., and Eisenberg, D. (2004) An amyloid-forming segment of beta-2-microglobulin suggests a molecular model for the fibril. Proc. Natl. Acad. Sci. U.S.A. 101, 10584-10589.
45. Richardson, J. S., and Richardson, D. C. (2002) Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl. Acad. Sci. U.S.A. 99, 2754-2759.
46. Litvinovich, S. V., Brew, S. A., Aota, S., Akiyama, S. K., Haudenschild, C., and Ingham, K. C. (1998) Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. J. Mol. Biol. 280, 245-258.
47. Canet, D., Sunde, M., Last, A. M., Miranker, A., Spencer, A., Robinson, C. V., and Dobson, C. M. (1999) Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants. Biochemistry 38, 6419-6427.
48. Khurana, R., Gillespie, J. R., Talapatra, A., Minert, L. J., Ionescu-Zanetti, C., Millett, I., and Fink, A. L. (2001) Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40, 3525-3535.
49. Ohnishi, S., and Takano, K. (2004) Amyloid fibrils from the viewpoint of protein folding. Cell. Mol. Life. Sci. 61, 511-524.
50. Uversky, V. N., and Fink, A. L. (2004) Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta 1698, 131-53.
51. McParland, V. J., Kalverda, A. P., Homans, S. W., and Radford, S. E. (2002) Structural properties of an amyloid precursor of beta-2-microglobulin. Nat. Struct. Biol. 9, 326-331.
52. Platt, G. W., McParland, V. J., Kalverda, A. P., Homans, S. W., and Radford, S. E. (2005) Dynamics in the unfolded state of beta-2-microglobulin studied by NMR. J. Mol. Biol. 346, 279-294.
53. Katou, H., Kanno, T., Hoshino, M., Hagihara, Y., Tanaka, H., Kawai, T., Hasegawa, K., Naiki, H., and Goto, Y. (2002) The role of disulfide bond in the amyloidogenic state of beta-2-microglobulin studied by heteronuclear NMR. Protein Sci. 11, 2218-2229.
54. Eakin, C. M., Knight, J. D., Morgan, C. J., Gelfand, M. A., and Miranker, A. D. (2002) Formation of a copper specific binding site in non-native states of beta-2-microglobulin. Biochemistry 41, 10646-10656.
55. Connors, L. H., Shirahama, T., Skinner, M., Fenves, A., and Cohen, A. S. (1985) In vitro formation of amyloid fibrils from intact beta-2-microglobulin. Biochem. Biophys. Res. Commun. 131, 1063-1068.
56. Colon, W., and Kelly, J. W. (1992) Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31, 8654-8660.
57. Lai, Z. H., Colon, W., and Kelly, J. W. (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35, 6470-6482.
58. Hurle, M. R., Helms, L. R., Li, L., Chan, W. N., and Wetzel, R. (1994) A role for destabilizing amino acid replacements in light-chain amyloidosis. Proc. Natl. Acad. Sci. U.S.A. 91, 5446-5450.
59. Nielsen, L., Frokjaer, S., Brange, J., Uversky, V. N., and Fink, A. L. (2001) Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 40, 8397-8409.
60. Chiba, T., Hagihara, Y., Higurashi, T., Hasegawa, K., Naiki, H., and Goto, Y. (2003) Amyloid fibril formation in the context of full-length protein. J. Biol. Chem. 278, 47016-47024.
61. Chiti, F., De Lorenzi, E., Grossi, S., Mangione, P., Giorgetti, S., Caccialanza, G., Dobson, C. M., Merlini, G., Ramponi, G., and Bellotti, V. (2001) A partially structured species of beta-2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis. J. Biol. Chem. 276, 46714-46721.
62. Gejyo, F., Kimura, H., Suzuki, S., Miyazaki, R., Naiki, H., and Nakakuki, K. (1997) Apolipoprotein E and alpha (1)-antichymotrypsin in dialysis-related amyloidosis. Kidney Int.g 52, S75-S78.
63. Jahn, T. R., Parker, M. J., Homans, S. W., and Radford, S. E. (2006) Amyloid Formation under physiological conditions proceeds via a nativelike folding intermediate. Nature Struct. Mol. Biol. In press.
64. Morten, I. J., Hewitt, E. W., and Radford, S. E. (2005) Beta-2-microglobulin and dialysis-related amyloidosis. In Protein Misfolding, aggregation and conformational diseases, (Uversky, V. N. and Fink, A. L., Eds.) Kluwer Academic/Plenum Publishers, Dordrecht, The Netherlands.
65. Pepys, M. B., Herbert, J., Hutchinson, W. L., Tennent, G. A., Lachmann, H. J., Gallimore, J. R., Lovat, L. B., Bartfai, T., Alanine, A., Hertel, C., Hoffmann, T., Jakob-Roeme, R., Norcross, R. D., Kemp, J. A., Yamamura, K., Suzuki, M., Taylor, G. W., Murray, S., Thompson, D., Purvis, A., Kolstoe, S., Wood, S. P., and Hawkins, P. N. (2002) Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 417, 254-259.
66. Verdone, G., Corazza, A., Viglino, P., Pettirossi, F., Giorgetti, S., Mangione, P., Andreola, A., Stoppini, M., Bellotti, V., and Esposito, G. (2002) The solution structure of human beta-2-microglobulin reveals the prodromes of its amyloid transition. Protein Sci. 11, 487-499.
67. DeLano, W. (2002) The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos, CA.